Navigation Links
Alzheimer's Treatment Trials May Have Special Challenges
Date:7/28/2008

Studies may need larger pools of participants to accurately assess if drugs are effective

MONDAY, July 28 (HealthDay News) -- It may be harder to prove the effectiveness of new Alzheimer's disease therapies, because researchers have been having a hard time finding measurable decline in memory and thinking processes in the placebo groups the drugs are being tested against, according to two new reports.

Several discoveries may explain this, according to the reports, which are expected to be presented Monday in Chicago at the Alzheimer's Association's International Conference on Alzheimer's Disease.

In the first study, researchers looked at 87 randomized, double-blind, placebo-controlled Alzheimer clinical trials conducted between 1991 and 2005. Their analysis help set conditions that may be optimal in these types of trials.

"Based on our analysis, the most reliable approach to maximize the likelihood for demonstrating efficacy is to have a placebo group size greater than 200 and to use (cognitive testing methods) at least four times and in English," researcher Dr. Lon S. Schneider, professor of psychiatry and neurology at the University of Southern California Keck School of Medicine, said in a news release issued from the conference.

The second study, which looked at trials of the drug donepezil during the 1990s, showed that the length of the placebo study may be of increasing importance. Placebo groups experienced slower declines in cognitive functions in trials done later in the decade, but this was mitigated when the trial period was longer.

"Our results indicate that patients with Alzheimer's entering the later clinical trials appear to be experiencing a slower rate of decline in memory and thinking processes," researcher Roy Jones, director of The Research Institute for the Care of Older People, in Bath, England, said in the same news release. "These observations are potentially
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting
3. Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi
4. Researchers disprove long-standing belief about HIV treatment
5. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
6. Clinical Trial Concluded For New Wrinkle Treatment
7. Has cancer spread? Research identifies best way to find answers so treatment can begin
8. Minimally Invasive Treatment Improves Male Fertility
9. Minimally invasive treatment improves male fertility
10. Clinical Trial for the Treatment of Inflammatory Bowel Disease Begins at Tel Aviv Sourasky Medical Center
11. Promising results in deep brain stimulation for patients with treatment-resistant depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Palm Beach, Florida (PRWEB) September 30, 2014 ... the No. 1 selling beauty brand on Amazon.com. , ... Sellers in their respective beauty categories on Amazon.com,” said Craig ... available in the UK on Amazon.co.uk and Canada on Amazon.ca ... latest products, which just launched earlier last month, are already ...
(Date:9/30/2014)... of Dental Medicine have been awarded a $11.8 million, ... Craniofacial Research, part of the National Institutes of Health, ... cleft lip and cleft palate and to expand the ... and Pennsylvania. , Orofacial clefts (OFCs), which are ... form when a baby,s mouth doesn,t develop properly during ...
(Date:9/30/2014)... of Michigan are pleased to announce an agreement to ... and Endocrinology , which is now open for submissions ... 2015. , The journal is led by Editor-in-Chief, ... of Metabolism, Endocrinology, and Diabetes, at the University of ... an international Editorial Board. , Clinical Diabetes ...
(Date:9/30/2014)... as an unusual character from a "Seinfeld" episode or ... genetic disease called SCID, short for severe combined immunodeficiency, ... contact because their bodies, natural defenses are too weak ... than 2,000 new births each year worldwide, SCID is ... a human immunodeficiency virus HIV/AIDS. , Now, using ...
(Date:9/30/2014)... and cardiac muscles contain few stem cells, heart ... heart attack. Now Tel Aviv University researchers are ... tissue engineering. , Dr. Tal Dvir and his ... Biotechnology, Department of Materials Science and Engineering, and ... sophisticated micro- and nanotechnological tools ranging in ...
Breaking Medicine News(10 mins):Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 3Health News:Pitt team searches for genetic roots of cleft lip, palate 2Health News:BioMed Central to publish open access journal in collaboration with the University of Michigan 2Health News:Virginia Tech researchers discover potential biomarker to detect 'bubble boy' disorder 2Health News:Virginia Tech researchers discover potential biomarker to detect 'bubble boy' disorder 3Health News:A heartbeat away? Hybrid 'patch' could replace transplants 2
... of Medicine in St. Louis claim that many children ... Their finding is totally reverse of the claims that ... said that 50 percent of the children who could ... ,"What we found was somewhat surprising," says Richard ...
... Young teenagers believe pregnancy would help them form connections ... boyfriend or creating a family of their own.// ... there are advantages in attaining motherhood early in life. ... the current issue of Pediatrics. ...
... from the University of Maryland School of Medicine, Galantamine, ... disease finds// a new role, in protecting people from ... The basis for further development of a safe and ... including nerve agents that have been used in chemical ...
... was launched in China on 7th August,2006//. ,Cancer is ... of Health department’s report in May. It accounts for ... and lifestyle factors are responsible for 80% of the cancers ... Treatment extends the lives of 60% of the cancer patients ...
... the Oman government's permission to carry out surgeries and ... group's new centre in the Omani capital Muscat. ... green signal to start our operation theatres, Intensive Care ... in the Times of Oman newspaper quoted V.T. Saileswaran ...
... compound derived from red algae to be a potent inhibitor ... warts//. The study has been published in the July ... thickening agent, blocks the Human Papillomavirus (HPV) from sticking to ... compound is a more natural and less expensive way to ...
Cached Medicine News:Health News:ADHD Children Are Being Under-Medicated 2Health News:ADHD Children Are Being Under-Medicated 3Health News:Teens and Pregnancy 2Health News:Teens and Pregnancy 3Health News:Alzheimer's Drug can be Used to Treat Nerve Agent and Pesticide Poisoning 2Health News:Alzheimer's Drug can be Used to Treat Nerve Agent and Pesticide Poisoning 3Health News:New Cancer-Blocking Algae Found 2
(Date:9/30/2014)... , Sept. 30, 2014 The Chinese wound ... population and rise in the incidence of lifestyle diseases, ... and in affordability of better quality of wound care ... market. Universal coverage of public health insurance schemes and ... stimulate demand. Based on the findings of primary and ...
(Date:9/30/2014)... Quebec , Sept. 30, 2014 Valeant ... TSX: VRX) today announced that the company,s ... Letter from the U.S. Food and Drug Administration (FDA) ... Company,s records with regards to Sculptra Aesthetic injectable, which ... Warning Letter pertains to the management of Valeant,s contract manufacturers ...
(Date:9/30/2014)... Sept. 30, 2014 The signing of ... and New Jersey Health Foundation (NJHF) to work ... care programs has been announced by Rodger ... Kessler Foundation and James M. Golubieski , ... "The experience of New Jersey Health Foundation in ...
Breaking Medicine Technology:China Wound Care Market 2China Wound Care Market 3Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2
... 2007 - Reata,Pharmaceuticals, Inc. today announced the ... Synthetic Triterpenoid programs in,the May 2007 issue ... article, "Triterpenoids and rexinoids as multifunctional,agents for ... researchers,and Reata scientific collaborators from the Dartmouth ...
... least,one-third of the time, the symptoms of bipolar ... children, it can be,difficult to distinguish bipolar symptoms ... issue of the Harvard Mental Health,Letter. , Children, ... cycle of distinct mood episodes of mania and ...
Cached Medicine Technology:Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 2Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 3Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 4Bipolar Disorder in Children Difficult to Diagnose, Reports the,Harvard Mental Health Letter 2
... A lower cost alternative to Equalizers, the ... transfers between two different vessel configurations. With the ... can be quickly and easily adjusted for test ... Ergonomic Design for Unparalleled Comfort Pick ...
... The Equalizer With 384 Well Plate ... the revolutionary features of the original Equalizerexpandable and ... autoclavable components, and in-lab calibration capabilities. In addition, ... tips down to 4.5mm for loading and accessing ...
Packaging: Set includes: Eight-channel pipette (10.8 mm with 0.5-5.0 μl capacity) 25 PrismStrip 96 tips with rack 2 FlexPlates with a holder...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
Medicine Products: